PF05212389

· Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF05212389, covering 2011-11-17 to 2011-11-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study Of Gastrointestinal Tolerability Of PF05212389 In Obese Subjects [Phase 1]